This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otto, M J
Right arrow Articles by McKinlay, M A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otto, M J
Right arrow Articles by McKinlay, M A

Next Article 

Antimicrob Agents Chemother. 1985 June; 27(6): 883-886

In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.

M J Otto, M P Fox, M J Fancher, M F Kuhrt, G D Diana and M A McKinlay

ABSTRACT

WIN 51711 (5-[7-[4-(4,5-dihydro-2-oxazolyl)phenoxy]heptyl]-3-methylisoxazole), a new antipicornavirus drug, is a potent inhibitor of human entero- and rhinoviruses at concentrations not inhibitory to HeLa cell growth. In plaque reduction assays, WIN 51711 reduced plaque formation by 9 enteroviruses and 33 rhinoviruses, with MICs of 0.004 to 0.17 and 0.004 to 6.2 micrograms/ml, respectively. Addition of WIN 51711 to infected cells at concentrations of 0.02 to 5.0 micrograms/ml reduced the yield of picornaviruses by 90%. Other RNA viruses (nonpicornaviruses) and DNA viruses were unaffected by the compound.

Antimicrob Agents Chemother. 1985 June; 27(6): 883-886




This article has been cited by other articles:

  • Shih, S.-R., Tsai, M.-C., Tseng, S.-N., Won, K.-F., Shia, K.-S., Li, W.-T., Chern, J.-H., Chen, G.-W., Lee, C.-C., Lee, Y.-C., Peng, K.-C., Chao, Y.-S. (2004). Mutation in Enterovirus 71 Capsid Protein VP1 Confers Resistance to the Inhibitory Effects of Pyridyl Imidazolidinone. Antimicrob. Agents Chemother. 48: 3523-3529 [Abstract] [Full Text]  
  • Zalman, L. S., Brothers, M. A., Dragovich, P. S., Zhou, R., Prins, T. J., Worland, S. T., Patick, A. K. (2000). Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor. Antimicrob. Agents Chemother. 44: 1236-1241 [Abstract] [Full Text]  
  • Dove, A. W., Racaniello, V. R. (2000). An Antiviral Compound That Blocks Structural Transitions of Poliovirus Prevents Receptor Binding at Low Temperatures. J. Virol. 74: 3929-3931 [Abstract] [Full Text]  
  • Hadfield, A. T., Diana, G. D., Rossmann, M. G. (1999). Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16. Proc. Natl. Acad. Sci. USA 96: 14730-14735 [Abstract] [Full Text]  
  • Hindiyeh, M., Li, Q.-H., Basavappa, R., Hogle, J. M., Chow, M. (1999). Poliovirus Mutants at Histidine 195 of VP2 Do Not Cleave VP0 into VP2 and VP4. J. Virol. 73: 9072-9079 [Abstract] [Full Text]  
  • Patick, A. K., Binford, S. L., Brothers, M. A., Jackson, R. L., Ford, C. E., Diem, M. D., Maldonado, F., Dragovich, P. S., Zhou, R., Prins, T. J., Fuhrman, S. A., Meador, J. W., Zalman, L. S., Matthews, D. A., Worland, S. T. (1999). In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease. Antimicrob. Agents Chemother. 43: 2444-2450 [Abstract] [Full Text]  
  • Pevear, D. C., Tull, T. M., Seipel, M. E., Groarke, J. M. (1999). Activity of Pleconaril against Enteroviruses. Antimicrob. Agents Chemother. 43: 2109-2115 [Abstract] [Full Text]  
  • Fohlman, J., Pauksen, K., Hyypia, T., Eggertsen, G., Ehrnst, A., Ilback, N.G., Friman, G. (1996). Antiviral Treatment With WIN 54 954 Reduces Mortality in Murine Coxsackievirus B3 Myocarditis. Circulation 94: 2254-2259 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»